Free tool
Diagnostics stocks
We cover 47 companies grouped under the Diagnostics theme. The median market value in the group is $46.17M. Across the group, the median move over the past trading day is −0.06%. 38% of the 45 with a 200-day average trade above it. Price change over the past year runs from −76.0% to +14.3% across the middle 80 percent of the group, with a median of −15.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
47 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| VOX.WA | Voxel S.A. | $376.42M | Small cap | −18.11% |
| N3B.F | Anbio Biotechnology | $361.87M | Small cap | −83.42% |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $339.65M | Small cap | +77.61% |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% |
| IDHC.L | Integrated Diagnostics Holdings plc | $298.80M | Small cap | +16.89% |
| ALERS.PA | Eurobio Scientific Société anonyme | $232.43M | Small cap | −21.89% |
| S2B.WA | Syn2bio S.A. | $151.66M | Small cap | +76.47% |
| 0ELV.L | Guerbet SA | $146.82M | Small cap | −62.50% |
| EKF.L | EKF Diagnostics Holdings plc | $145.56M | Small cap | −15.56% |
| SCP.WA | Scope Fluidics S.A. | $120.06M | Small cap | −9.90% |
| S84.F | Scope Fluidics S.A. | $118.77M | Small cap | −10.43% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% |
| BIOPOR.CO | BioPorto A/S | $93.40M | Micro cap | −3.13% |
| 7V0.DE | Novogenia AG | $89.54M | Micro cap | −25.00% |
| ALKLH.PA | Klea Holding SA | $54.74M | Micro cap | −32.00% |
| BIOBV.HE | Biohit Oyj | $46.63M | Micro cap | −8.13% |
| 0DRP.L | Biohit Oyj | $45.72M | Micro cap | −6.31% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| ALNOV.PA | Novacyt S.A. | $42.69M | Micro cap | +7.38% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| ABDX.L | Abingdon Health Plc | $36.92M | Micro cap | +104.76% |
| ACARIX.ST | Acarix AB (publ) | $32.23M | Micro cap | −14.11% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| NN6.DE | NanoRepro AG | $27.65M | Micro cap | −4.90% |
| ALIKO.PA | Ikonisys S.A. | $26.94M | Micro cap | −6.58% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| ALBIO.PA | Biosynex SA | $19.25M | Micro cap | −23.23% |
| URT.WA | Urteste S.A. | $17.98M | Micro cap | −15.31% |
| GMT.WA | Genomtec S.A. | $17.34M | Micro cap | −40.65% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.67M | Micro cap | −30.12% |
| BACTIQ.CO | BactiQuant A/S | $13.22M | Micro cap | −10.42% |
| BOUL.ST | Boule Diagnostics AB (publ) | $12.76M | Micro cap | −47.36% |
| CRM.WA | PZ Cormay S.A. | $12.02M | Micro cap | +3.16% |
| BMX.WA | BioMaxima S.A. | $11.52M | Micro cap | −20.78% |
| GENI.L | GENinCode Plc | $9.25M | Micro cap | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | $8.78M | Micro cap | −88.08% |
| OBD.L | Oxford BioDynamics Plc | $6.85M | Micro cap | −74.11% |
| ALPRE.PA | Predilife S.A. | $5.10M | Micro cap | −65.74% |
| 0G8X.L | Immunovia AB (publ) | $499.30K | Micro cap | −78.96% |
| 0A50.L | Co-Diagnostics, Inc. | — | — | −87.47% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.